Schedule of Purchase Price Allocated to Acquired Assets (Details) - USD ($) $ in Thousands		12 Months Ended
	Oct. 09, 2024	Dec. 31, 2024	Dec. 31, 2023
Asset Acquisition [Line Items]
Cash payment		$ 1,500
Sequence LifeScience Inc [Member]
Asset Acquisition [Line Items]
Cash payment	$ 1,500
Contingent consideration	650
Total consideration	2,150
Inventory	2,150
Total assets acquired	$ 2,150